JHBCX
Price
$65.99
Change
-$1.16 (-1.73%)
Updated
Jul 13 closing price
Net Assets
5.78B
RGACX
Price
$82.84
Change
-$1.34 (-1.59%)
Updated
Jul 13 closing price
Net Assets
356.86B
Interact to see
Advertisement

JHBCX vs RGACX

JHBCX vs RGACX Comparison Chart in %
View a ticker or compare two or three
VS
JHBCX vs. RGACX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JHBCX is a Buy and RGACX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 357B vs. JHBCX (5.78B). JHBCX (0.00) and RGACX (0.00) have matching dividends . JHBCX was incepted earlier than RGACX: JHBCX (21 years) vs RGACX (24 years). RGACX (0.93) is less costly to investors than JHBCX (0.76). RGACX is a more actively managed with annual turnover of: 32.00 vs. JHBCX (29.00). JHBCX has a lower initial minimum investment than RGACX: JHBCX (0) vs RGACX (250). RGACX annual gain was more profitable for investors over the last year : 3.68 vs. JHBCX (1.90). RGACX return over 5 years is better than : 13.46 vs. JHBCX (3.96).
JHBCXRGACXJHBCX / RGACX
Total Expense Ratio0.750.9381%
Annual Report Gross Expense Ratio0.760.9382%
Fund Existence21 years24 years-
Gain YTD1.7896.95926%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets5.78B357B2%
Annual Yield % from dividends0.000.00-
Returns for 1 year1.903.6852%
Returns for 3 years47.2637.13127%
Returns for 5 years3.9613.4629%
Returns for 10 years111.1797.58114%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
USPH71.59-0.95
-1.31%
US Physical Therapy
NBP1.86-0.04
-2.11%
NovaBridge Biosciences
LEGN25.75-1.33
-4.91%
Legend Biotech Corp
AUID1.09-0.07
-6.03%
authID
ALAB362.05-50.92
-12.33%
Astera Labs